{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:45:41Z","timestamp":1791830741799,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,19]]},"DOI":"10.7759\/cureus.79304","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:48:22Z","timestamp":1739987302000},"source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory Bowel Disease and Stroke: Exploring Hidden Vascular Risks"],"prefix":"10.7759","author":[{"given":"Abdallah","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysoon A","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2019.1574569","article-title":"Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis","volume":"13","author":"Greuter T","year":"2019","unstructured":"Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019, 13:307-17. 10.1080\/17474124.2019.1574569","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref2","unstructured":"World Stroke Organization. Impact of stroke. (2023). Accessed. November 10, 2024: https:\/\/www.world-stroke.org\/world-stroke-day-campaign\/about-stroke\/impact-of-stroke."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30073-4","article-title":"Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"15","author":"Feigin VL","year":"2016","unstructured":"Feigin VL, Roth GA, Naghavi M, et al.. Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016, 15:913-24. 10.1016\/S1474-4422(16)30073-4","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016676285","article-title":"Global stroke statistics","volume":"12","author":"Thrift AG","year":"2017","unstructured":"Thrift AG, Thayabaranathan T, Howard G, et al.. Global stroke statistics. Int J Stroke. 2017, 12:13-32. 10.1177\/1747493016676285","journal-title":"Int J Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S233909","article-title":"The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke","volume":"15","author":"Pawluk H","year":"2020","unstructured":"Pawluk H, Wo\u017aniak A, Grze\u015bk G, et al.. The role of selected pro-inflammatory cytokines in pathogenesis of ischemic stroke. Clin Interv Aging. 2020, 15:469-84. 10.2147\/CIA.S233909","journal-title":"Clin Interv Aging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2159","article-title":"Increased risk of stroke among patients with inflammatory bowel disease: a PRISMA-compliant meta-analysis","volume":"11","author":"Chen Y","year":"2021","unstructured":"Chen Y, Wang X. Increased risk of stroke among patients with inflammatory bowel disease: a PRISMA-compliant meta-analysis. Brain Behav. 2021, 11:e02159. 10.1002\/brb3.2159","journal-title":"Brain Behav"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00727","article-title":"A systematic review of the microbiome in children with neurodevelopmental disorders","volume":"10","author":"Lacorte E","year":"2019","unstructured":"Lacorte E, Gervasi G, Bacigalupo I, Vanacore N, Raucci U, Parisi P. A systematic review of the microbiome in children with neurodevelopmental disorders. Front Neurol. 2019, 10:727. 10.3389\/fneur.2019.00727","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S250182","article-title":"The risk of cerebrovascular accidents in inflammatory bowel disease in the United States: a population-based national study","volume":"13","author":"Ghoneim S","year":"2020","unstructured":"Ghoneim S, Shah A, Dhorepatil A, Butt MU, Waghray N. The risk of cerebrovascular accidents in inflammatory bowel disease in the United States: a population-based national study. Clin Exp Gastroenterol. 2020, 13:123-9. 10.2147\/CEG.S250182","journal-title":"Clin Exp Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","author":"Kaptoge S","year":"2012","unstructured":"Kaptoge S, Di Angelantonio E, Pennells L, et al.. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012, 367:1310-20. 10.1056\/NEJMoa1107477","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i11.553","article-title":"Cardiovascular implications of inflammatory bowel disease: an updated review","volume":"15","author":"Bhardwaj A","year":"2023","unstructured":"Bhardwaj A, Singh A, Midha V, Sood A, Wander GS, Mohan B, Batta A. Cardiovascular implications of inflammatory bowel disease: an updated review. World J Cardiol. 2023, 15:553-70. 10.4330\/wjc.v15.i11.553","journal-title":"World J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier RJ","year":"2007","unstructured":"Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007, 448:427-34. 10.1038\/nature06005","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins L","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al.. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012, 491:119-24. 10.1038\/nature11582","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn's disease","volume":"204","author":"Baumgart DC","year":"2013","unstructured":"Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2013, 204:1590-605. 10.1016\/S0140-6736(12)60026-9","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner JR","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009, 9:799-809. 10.1038\/nri2653","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.104182","article-title":"Inflammatory bowel disease: is it really just another break in the wall?","volume":"56","author":"Weber CR","year":"2007","unstructured":"Weber CR, Turner JR. Inflammatory bowel disease: is it really just another break in the wall?. Gut. 2007, 56:6-8. 10.1136\/gut.2006.104182","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath MF","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014, 14:329-42. 10.1038\/nri3661","journal-title":"Nat Rev Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham C","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009, 361:2066-78. 10.1056\/NEJMra0804647","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.390","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"14","author":"Shih DQ","year":"2008","unstructured":"Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2008, 14:390-400. 10.3748\/wjg.14.390","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.mib.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities","volume":"12 Suppl 1","author":"Hanauer SB","year":"2006","unstructured":"Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006, 12 Suppl 1:S3-9. 10.1097\/01.mib.0000195385.19268.68","journal-title":"Inflamm Bowel Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic AD","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014, 146:1489-99. 10.1053\/j.gastro.2014.02.009","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor RB","year":"2006","unstructured":"Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006, 3:390-407. 10.1038\/ncpgasthep0528","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura Y","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, et al.. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001, 411:603-6. 10.1038\/35079114","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux JD","year":"2007","unstructured":"Rioux JD, Xavier RJ, Taylor KD, et al.. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 2007, 39:596-604. 10.1038\/ng2032","journal-title":"Nat Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2008.05.009","article-title":"Intestinal fibrosis in inflammatory bowel disease - current knowledge and future perspectives","volume":"2","author":"Rieder F","year":"2008","unstructured":"Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease - current knowledge and future perspectives. J Crohns Colitis. 2008, 2:279-90. 10.1016\/j.crohns.2008.05.009","journal-title":"J Crohns Colitis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.10.009","article-title":"Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland","volume":"6","author":"Manninen P","year":"2012","unstructured":"Manninen P, Karvonen AL, Huhtala H, et al.. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis. 2012, 6:524-8. 10.1016\/j.crohns.2011.10.009","journal-title":"J Crohns Colitis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese S","year":"2011","unstructured":"Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011, 365:1713-25. 10.1056\/NEJMra1102942","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247515","article-title":"Molecular links and clinical effects of inflammation and metabolic background on ischemic stroke: an update review","volume":"13","author":"Pacinella G","year":"2024","unstructured":"Pacinella G, Ciaccio AM, Tuttolomondo A. Molecular links and clinical effects of inflammation and metabolic background on ischemic stroke: an update review. J Clin Med. 2024, 13:7515. 10.3390\/jcm13247515","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson GK","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352:1685-95. 10.1056\/NEJMra043430","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.03.002","article-title":"Inflammatory bowel disease: the role of environmental factors","volume":"3","author":"Danese S","year":"2004","unstructured":"Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004, 3:394-400. 10.1016\/j.autrev.2004.03.002","journal-title":"Autoimmun Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000116773","article-title":"Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects","volume":"26","author":"Papa A","year":"2008","unstructured":"Papa A, Scaldaferri F, Danese S, et al.. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis. 2008, 26:149-55. 10.1159\/000116773","journal-title":"Dig Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder F","year":"2017","unstructured":"Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017, 152:340-50.e6. 10.1053\/j.gastro.2016.09.047","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge MJ","year":"2010","unstructured":"Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010, 375:657-63. 10.1016\/S0140-6736(09)61963-2","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Singh S","year":"2014","unstructured":"Singh S, Singh H, Loftus EV Jr, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014, 12:382-93.e1: quiz e22. 10.1016\/j.cgh.2013.08.023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein CN","year":"2008","unstructured":"Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008, 6:41-5. 10.1016\/j.cgh.2007.09.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro R","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017, 389:1756-70. 10.1016\/S0140-6736(16)32126-2","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-012-1059-0","article-title":"Protein C anticoagulant and cytoprotective pathways","volume":"95","author":"Griffin JH","year":"2012","unstructured":"Griffin JH, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012, 95:333-45. 10.1007\/s12185-012-1059-0","journal-title":"Int J Hematol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.07.004","article-title":"Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn\u2019s disease","volume":"163","author":"Leibovitzh H","year":"2022","unstructured":"Leibovitzh H, Lee SH, Xue M, et al.. Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn\u2019s disease. Gastroenterology. 2022, 163:1364-76.e10. 10.1053\/j.gastro.2022.07.004","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1343886","article-title":"Risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"39","author":"Koutroumpakis EI","year":"2013","unstructured":"Koutroumpakis EI, Tsiolakidou G, Koutroubakis IE. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost. 2013, 39:461-8. 10.1055\/s-0033-1343886","journal-title":"Semin Thromb Hemost"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.4","article-title":"Dynamics of the human gut microbiome in inflammatory bowel disease","volume":"2","author":"Halfvarson J","year":"2017","unstructured":"Halfvarson J, Brislawn CJ, Lamendella R, et al.. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017, 2:17004. 10.1038\/nmicrobiol.2017.4","journal-title":"Nat Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-014-1862-6","article-title":"Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study","volume":"29","author":"Keller JJ","year":"2014","unstructured":"Keller JJ, Wang J, Huang YL, et al.. Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study. Int J Colorectal Dis. 2014, 29:805-12. 10.1007\/s00384-014-1862-6","journal-title":"Int J Colorectal Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-015-2132-y","article-title":"Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study","volume":"30","author":"Keller JJ","year":"2015","unstructured":"Keller JJ, Wang J, Hwang YL, et al.. Increased risk of stroke among patients with Crohn's disease: a population-based matched cohort study. Int J Colorectal Dis. 2015, 30:645-53. 10.1007\/s00384-015-2132-y","journal-title":"Int J Colorectal Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut312","article-title":"Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study","volume":"16","author":"Kristensen SL","year":"2014","unstructured":"Kristensen SL, Lindhardsen J, Ahlehoff O, et al.. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace. 2014, 16:477-84. 10.1093\/europace\/eut312","journal-title":"Europace"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan A","year":"2014","unstructured":"Dregan A, Charlton J, Chowienczyk P, Gulliford MC. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation. 2014, 130:837-44. 10.1161\/CIRCULATIONAHA.114.009990","journal-title":"Circulation"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2009.001230","article-title":"International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets","volume":"17","author":"Steindel SJ","year":"2010","unstructured":"Steindel SJ. International classification of diseases, 10th edition, clinical modification and procedure coding system: descriptive overview of the next generation HIPAA code sets. J Am Med Inform Assoc. 2010, 17:274-82. 10.1136\/jamia.2009.001230","journal-title":"J Am Med Inform Assoc"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2014.05.009","article-title":"Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study","volume":"25","author":"Huang WS","year":"2014","unstructured":"Huang WS, Tseng CH, Chen PC, Tsai CH, Lin CL, Sung FC, Kao CH. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study. Eur J Intern Med. 2014, 25:561-5. 10.1016\/j.ejim.2014.05.009","journal-title":"Eur J Intern Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-3-424","article-title":"The International Classification of Diseases: ninth revision (ICD-9)","volume":"88","author":"Slee VN","year":"1978","unstructured":"Slee VN. The International Classification of Diseases: ninth revision (ICD-9). Ann Intern Med. 1978, 88:424-6. 10.7326\/0003-4819-88-3-424","journal-title":"Ann Intern Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory bowel disease and cardiovascular diseases","volume":"135","author":"Chen B","year":"2022","unstructured":"Chen B, Collen LV, Mowat C, et al.. Inflammatory bowel disease and cardiovascular diseases. Am J Med. 2022, 135:1453-60. 10.1016\/j.amjmed.2022.08.012","journal-title":"Am J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao CW","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al.. Heart Disease and Stroke Statistics-2023 update: a report from the American Heart Association. Circulation. 2023, 147:e93-e621. 10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207480","article-title":"Long-term risk of stroke in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study, 1969-2019","volume":"101","author":"Sun J","year":"2023","unstructured":"Sun J, Halfvarson J, Appelros P, et al.. Long-term risk of stroke in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study, 1969-2019. Neurology. 2023, 101:e653-64. 10.1212\/WNL.0000000000207480","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04674.x","article-title":"Management consensus of inflammatory bowel disease for the Asia-Pacific region","volume":"21","author":"Ouyang Q","year":"2006","unstructured":"Ouyang Q, Tandon R, Goh KL, et al.. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006, 21:1772-82. 10.1111\/j.1440-1746.2006.04674.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.202","article-title":"Epidemiology, risk factors and management of cardiovascular diseases in IBD","volume":"12","author":"Singh S","year":"2015","unstructured":"Singh S, Kullo IJ, Pardi DS, Loftus EV Jr. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015, 12:26-35. 10.1038\/nrgastro.2014.202","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303285","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study","volume":"62","author":"Rungoe C","year":"2013","unstructured":"Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2013, 62:689-94. 10.1136\/gutjnl-2012-303285","journal-title":"Gut"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00021-8","article-title":"Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus","volume":"7","author":"Ananthakrishnan AN","year":"2022","unstructured":"Ananthakrishnan AN, Kaplan GG, Bernstein CN, et al.. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus. Lancet Gastroenterol Hepatol. 2022, 7:666-78. 10.1016\/S2468-1253(22)00021-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002635","article-title":"Tofacitinib in acute severe ulcerative colitis (TACOS): a randomized controlled trial","volume":"119","author":"Singh A","year":"2024","unstructured":"Singh A, Goyal MK, Midha V, et al.. Tofacitinib in acute severe ulcerative colitis (TACOS): a randomized controlled trial. Am J Gastroenterol. 2024, 119:1365-72. 10.14309\/ajg.0000000000002635","journal-title":"Am J Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2022.36.s1.r3715","article-title":"The role of vitamin D and platelet aggregation in patients with hypertension","volume":"36","author":"Vuthaluru AR","year":"2022","unstructured":"Vuthaluru AR, Goyal MK. The role of vitamin D and platelet aggregation in patients with hypertension. FASEB J. 2022, 36:10.1096\/fasebj.2022.36.s1.r3715","journal-title":"FASEB J"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/codi.14853","article-title":"Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review","volume":"22","author":"McKechnie T","year":"2020","unstructured":"McKechnie T, Wang J, Springer JE, Gross PL, Forbes S, Eskicioglu C. Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review. Colorectal Dis. 2020, 22:663-78. 10.1111\/codi.14853","journal-title":"Colorectal Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: a concise review","volume":"2","author":"Wu H","year":"2022","unstructured":"Wu H, Hu T, Hao H, Hill MA, Xu C, Liu Z. Inflammatory bowel disease and cardiovascular diseases: a concise review. Eur Heart J Open. 2022, 2:oeab029. 10.1093\/ehjopen\/oeab029","journal-title":"Eur Heart J Open"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53 Suppl 5","author":"Carter MJ","year":"2004","unstructured":"Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004, 53 Suppl 5:V1-16. 10.1136\/gut.2004.043372","journal-title":"Gut"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2014.00028","article-title":"The gut microbiota in mouse models of inflammatory bowel disease","volume":"4","author":"Gkouskou KK","year":"2014","unstructured":"Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol. 2014, 4:28. 10.3389\/fcimb.2014.00028","journal-title":"Front Cell Infect Microbiol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/ar4175","article-title":"Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage","volume":"15 Suppl 3","author":"Sostres C","year":"2013","unstructured":"Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2013, 15 Suppl 3:S3. 10.1186\/ar4175","journal-title":"Arthritis Res Ther"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31072","article-title":"A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease","volume":"122","author":"Sandborn WJ","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et al.. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002, 122:512-30. 10.1053\/gast.2002.31072","journal-title":"Gastroenterology"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study","volume":"389","author":"Kugathasan S","year":"2017","unstructured":"Kugathasan S, Denson LA, Walters TD, et al.. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017, 389:1710-18. 10.1016\/S0140-6736(17)30317-3","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.03.004","article-title":"Corrigendum to 'ESPEN guideline: Clinical nutrition in inflammatory bowel disease' [Clinical Nutrition 36 (2) (2016) 321-347]","volume":"38","author":"Forbes A","year":"2019","unstructured":"Forbes A, Escher J, H\u00e9buterne X, et al.. Corrigendum to 'ESPEN guideline: Clinical nutrition in inflammatory bowel disease' [Clinical Nutrition 36 (2) (2016) 321-347]. Clin Nutr. 2019, 38:1485. 10.1016\/j.clnu.2019.03.004","journal-title":"Clin Nutr"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death - a Danish nationwide cohort study","volume":"8","author":"Kristensen SL","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, et al.. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death - a Danish nationwide cohort study. PLoS One. 2013, 8:e56944. 10.1371\/journal.pone.0056944","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337863-inflammatory-bowel-disease-and-stroke-exploring-hidden-vascular-risks","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:48:26Z","timestamp":1739987306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337863-inflammatory-bowel-disease-and-stroke-exploring-hidden-vascular-risks"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.79304","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}